Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 1399  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
This article has been cited by
1Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence
Jonathan A. Bernstein,Abhishek Kavati,Michael D. Tharp,Benjamin Ortiz,Karen MacDonald,Kris Denhaerynck,Ivo Abraham
Expert Opinion on Biological Therapy.2018;18(4)425
[DOI]
2Omalizumab in the Treatment of Chronic Urticaria
L. Francés,M. Leiva-Salinas,J.F. Silvestre
Actas Dermo-Sifiliográficas (English Edition).2014;105(1)45
[DOI]
3Wytyczne EAACI/GA2LEN/EDF/WAO dotyczace definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami
T. Zuberbier,W. Aberer,R. Asero,C. Bindslev-Jensen,Z. Brzoza,G.W. Canonica,M.K. Church,L.F. Ensina,A. Giménez-Arnau,K. Godse,M. Gonçalo,C. Grattan,J. Hebert,M. Hide,A. Kaplan,A. Kapp,A.H. Abdul Latiff,P. Mathelier-Fusade,M. Metz,A. Nast,S.S. Saini,M. Sánchez-Borges,P. Schmid-Grendelmeier,F.E.R. Simons,P. Staubach,G. Sussman,E. Toubi,G.A. Vena,B. Wedi,X.J. Zhu,M. Maurer
Alergologia Polska - Polish Journal of Allergology.2015;2(1)T1
[DOI]
4Successful Treatment of the Different Urticaria Subtypes
Bettina Wedi
Current Dermatology Reports.2015;4(2)71
[DOI]
5Omalizumab en el tratamiento de la urticaria crónica
L. Francés,M. Leiva-Salinas,J.F. Silvestre
Actas Dermo-Sifiliográficas.2014;105(1)45
[DOI]
6The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria
Tse Wen Chang,Christina Chen,Chien-Jen Lin,Martin Metz,Martin K. Church,Marcus Maurer
Journal of Allergy and Clinical Immunology.2015;135(2)337
[DOI]
7Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
Kiran Godse,Murlidhar Rajagopalan,Mukesh Girdhar,Sanjiv Kandhari,Bela Shah,PrashantN Chhajed,Sushil Tahiliani,DS Krupa Shankar,Vijay Somani,Vijay Zawar
Indian Dermatology Online Journal.2016;7(1)6
[DOI]
8Omalizumab in chronic urticaria
Martin Metz,Marcus Maurer
Current Opinion in Allergy & Clinical Immunology.2012;12(4)406
[DOI]
9The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
T. Zuberbier,W. Aberer,R. Asero,C. Bindslev-Jensen,Z. Brzoza,G. W. Canonica,M. K. Church,L. F. Ensina,A. Giménez-Arnau,K. Godse,M. Gonçalo,C. Grattan,J. Hebert,M. Hide,A. Kaplan,A. Kapp,A. H. Abdul Latiff,P. Mathelier-Fusade,M. Metz,A. Nast,S. S. Saini,M. Sánchez-Borges,P. Schmid-Grendelmeier,F. E. R. Simons,P. Staubach,G. Sussman,E. Toubi,G. A. Vena,B. Wedi,X. J. Zhu,M. Maurer
Allergy.2014;69(7)868
[DOI]
10The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Karsten Weller,Marcus Maurer
Allergy.2014;69(7)210
[DOI]
11Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
Michael D. Tharp,Jonathan A. Bernstein,Abhishek Kavati,Benjamin Ortiz,Karen MacDonald,Kris Denhaerynck,Ivo Abraham,Christopher S. Lee
JAMA Dermatology.2019;155(1)29
[DOI]
  Search 
  The Journal 
  The Association 
  Dermalinks  
  Book of Abstracts 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts